Adding Ibrutinib to RICE or RVICI Provides No Benefit in Pediatric Rel/Ref B-NHL
Researchers sought to determine whether adding ibrutinib to multiagent chemotherapy would improve survival in pediatric patients with B-NHL.
Diagnosis & Disease Information
Adding Bortezomib to DRC Does Not Improve PFS in Waldenström Macroglobulinemia
Researchers sought to determine whether adding bortezomib to DRC would improve survival in patients with Waldenström macroglobulinemia.
Glofitamab Can Provide Lasting Remissions in Heavily Pretreated Large B-Cell Lymphoma
Progression is “uncommon” in patients with relapsed/refractory large B-cell lymphoma who are in complete remission at the end of glofitamab treatment.
Adding Ibrutinib to Induction and Maintenance Improves FFS in Mantle Cell Lymphoma
Adding ibrutinib to induction and maintenance after transplant improves failure-free survival in patients with mantle cell lymphoma, results of the TRIANGLE study suggest.
Zandelisib Plus Zanubrutinib Elicits High ORRs in Relapsed/Refractory FL or MCL
The combination of zandelisib and zanubrutinib produced high overall response rates in patients with relapsed/refractory follicular lymphoma or mantle cell lymphoma.
BTK Inhibitor With CAR T-Cell Therapy Deemed Effective in Relapsed/Refractory MCL
The combination of ibrutinib and tisagenlecleucel produced durable responses in patients with relapsed/refractory mantle cell lymphoma.
Outcomes After BTK Inhibitor Failure in Rel/Ref Mantle Cell Lymphoma
A real-world study provides a benchmark for survival in MCL patients for whom BTK inhibitor treatment has failed, according to researchers.
Consolidative Stem Cell Transplant May Improve Outcomes Among Patients With PTCL
Researchers sought to determine whether patients with PTCL who have a complete response after A+CHP would benefit from SCT.
Acute Kidney Injury After CAR-T Therapy for Non-Hodgkin Lymphoma
Researchers sought to determine the incidence and possible risk factors of acute kidney injury in patients undergoing a chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
Real-World Analysis Reveals Treatment, Survival Trends in Mantle Cell Lymphoma
Researchers sought to determine the treatment and survival trends for patients with mantle cell lymphoma.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...